System Transmission

Top Signal

100#1 JOB

Activity

2163Ripe

+917 today

System

Live1m

Terminal Asset View

stockNASDAQ

MDGL

$444.83+1.39%

Madrigal Pharmaceuticals Inc

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

46Neutral

Live Analysis Active

Company Mission

Madrigal Pharmaceuticals creates experimental medicines to treat serious liver conditions like non-alcoholic steatohepatitis (NASH), which is fatty liver disease. Doctors and hospitals would use these drugs to help patients with liver problems. The company makes money by conducting clinical trials and hopes to earn revenue from selling approved drugs in the future.

MDG

Industry Context

Biotechnology companies develop new medicines through research and clinical trials. This sector is highly volatile because drug approvals can dramatically change a company's value. Investors watch for clinical trial results and regulatory decisions.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

54Matrix

Market Momentum

45.8— Holding Steady

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

1.39%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing MDGL across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 08:21 AM UTC

As-of 03-15-2026 08:06 UTC

Develops a drug to treat fatty liver disease and makes money by selling this medicine to hospitals and pharmacies.

Price below key moving averages for the past month, suggesting a downtrend as sellers maintain control showing consolidation pattern.

Biotech sector showing volatility as FDA decisions approach, watch for price action near recent lows, suggesting recent lows.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...